Meta Platforms
META
Petroleo Brasileiro SA Petrobras
PBR
Ecopetrol
EC
Vale SA
VALE
Tesla
TSLA
US Stock MarketDetailed Quotes
ENSG Ensign
- 130.950
- -2.230-1.67%
Close Jan 10 16:00 ET
- 130.010
- -0.940-0.72%
Pre 08:12 ET
7.50BMarket Cap31.71P/E (TTM)
132.595High130.310Low360.74KVolume131.680Open133.180Pre Close47.26MTurnover0.66%Turnover Ratio35.88P/E (Static)57.30MShares158.38852wk High4.29P/B7.21BFloat Cap110.49152wk Low0.24Dividend TTM55.08MShs Float158.388Historical High0.18%Div YieldTTM1.72%Amplitude3.285Historical Low131.014Avg Price1Lot Size
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Ensign Stock Forum
Guess the Stock E57 Answers:
Company A: ADBE
Company B: SAP
Company C: ADSK
Market Capitalization comparison:
Company A > Company B > Company C
Guess the Stock E55 Answers:
Company A: HCA
Company B: UHS
Company C: ENSG
Market Capitalization comparison:
Company A > Company B > Company C
Thank you ALL for joining the Guess t...
• $Actinium (ATNM.US)$ +30.81% (Actinum Pharma and Immedica to commercialize lomab-B (1311 apamistamab) in Europe the Middle East and North Africa)
• $Aeglea BioTherapeutics (AGLE.US)$ +18.11% (presents additional data from PEACE phase 3 study of Pegzilarginase; submits BLA to FDA for Pegzilarginase)
• $Grid Dynamics (GDYN.US)$ +5% (expands in Europe ceases operations in Russia)
• $Artisan Partners Asset Management (APAM.US)$ +4....
No comment yet